Immutable's Price Surge: A 3% Rise in 24 Hours
Immutable's Price Surge Overview
Immutable's price has experienced a significant increase of 3.23% within the last 24 hours, now standing at a value of $1.81. Over the past week, the cryptocurrency has shown a remarkable growth trend, jumping from $1.48 to its current rate, resulting in an overall gain of more than 23%. It's worth noting that Immutable's all-time high reached an impressive $9.52.
Price Movement Analysis
To understand Immutable's performance better, we can look at its price dynamics over different time frames. In the last 24 hours, the price fluctuation of the coin has been monitored closely, illustrating how it has responded to market conditions. Swinging movements can be depicted in the charts that track both intraday and weekly price behavior. The use of Bollinger Bands aids in visualizing its price volatility; broader bands indicate a greater level of price fluctuation.
Trading Volume and Market Metrics
Despite the price rise, the trading volume for Immutable has seen a notable decline of 21.0% over the past week. However, in contrast, the circulating supply has increased slightly by 0.28%, now reaching approximately 1.61 billion tokens. This circulating supply represents about 80.26% of the cryptocurrency's maximum supply of 2.00 billion, illustrating a significant portion of the total availability in circulation. The current market capitalization of IMX stands at approximately $2.92 billion, positioning it at #38 in market cap rankings.
Market Influences on Immutable
The fluctuations and performance of Immutable are indicative of broader market trends, and it's insightful to consider the various factors that may influence its price. Market investor sentiment, the overall health of the cryptocurrency space, and changes in adoption rates can impact the perception and demand for IMX. Understanding these dynamics is crucial for potential investors and enthusiasts.
Future Outlook for Immutable
Looking towards the future, it’s essential to gauge what potential developments could influence the price of Immutable. With ongoing advancements and increasing attention on this cryptocurrency, the potential for price growth could remain robust. Keeping a watchful eye on market trends and project developments will be key in understanding IMX’s trajectory.
Frequently Asked Questions
What is the current price of Immutable (IMX)?
The current price of Immutable is $1.81, reflecting a 3.23% increase over the past 24 hours.
How much has Immutable gained in the last week?
In the past week, Immutable has risen by over 23%, going from $1.48 to $1.81.
What is the all-time high price of Immutable?
Immutable's all-time high price is $9.52.
What is Immutable's market cap ranking?
Immutable is currently ranked #38 in market capitalization, with a total of about $2.92 billion.
How does the trading volume of Immutable compare to its price surge?
Even with the recent price surge, Immutable has seen a decline in trading volume by 21.0% over the past week.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Molecular Partners Set to Present Groundbreaking Cancer Therapy
- Tornator Secures Major Financial Backing with New Loans
- Investors of Equity LifeStyle Properties Should Act Now
- Copenhagen's Green Tourism Initiative: A Shift for Sustainability
- Copenhagen's Bold Tourism Strategy for a Sustainable Future
- Investor Participation Urged in Verve Therapeutics Case
- Legal Action for Investors of WEBTOON Entertainment Ltd.
- China's Market Rally Sparks Global Economic Optimism
- Toyota Sees Continued Production Decline Amid Challenges
- Join the Excitement: Discover $BC Mining Rush's Daily Prizes
Recent Articles
- Recent Surge in OKB Prices Highlights Market Movements
- Veteran Ventures Capital Boosts Space Propulsion via Agile Investment
- Ispire Technology Inc Reports Impressive 31.4% Revenue Growth
- Cotopaxi Launches Music For Good Campaign with Key Artists
- ASCO's SourcePacT: A Game-Changer for Emergency Power Solutions
- Capitalizing on Village Farms as the Cannabis Landscape Shifts
- Natural Gas Demand Surges as Storage Levels Drop Below Estimates
- DealerOn Enhances Offerings with Strategic Acquisition of Sincro
- BTIG Suggests Timing for Profit Taking in Precious Metals
- Ashley Tisdale Brings Unique Style to Rugs USA with New Line
- Patterson UTI Energy Faces Challenges as Stocks Hit Low
- Groundbreaking Study on ALS Uses Innovative Technology
- Southwest Airlines Soars with Positive Ratings and Plans
- Innovative Tablet Case Provides Safety for Young Users
- Equinor ASA Achieves 52-Week Low as Market Adjusts Strategies
- Revolutionizing Employee Benefits: Remodel Health's ICHRA+®
- Truist Holds Steady on QuantumScape: Insights and Prospects
- New Study Reveals Oral Bacteria's Impact on Cancer Risk
- Pyrophyte Acquisition Corp. Stock Hits Record $11.54 High
- KeyBank Report Reveals Growing Confidence Among Business Leaders
- HTX DAO Enhances Global Reach with Focus on CIS Region
- Essential Strategies to Overcome Needle Anxiety for All Ages
- KLTO Stock Plummets to 52-Week Low as Markets Struggle
- National Bank Grants Outperform Rating to Descartes Systems
- Wells Fargo Seeks to Lift Asset Cap with Fed's Review Submission
- Athens General Composite Sees Gains as Market Performance Improves
- Tel Aviv Stock Exchange Surges: TA 35 Hits Record Heights
- Norway Stock Markets Experience Decline Amid Weakness
- Market Cap Movers: Alibaba and KE Holdings Surge in Trading
- Guardian Pharmacy Gains 3% in Market Debut on NYSE
- Bavarian Nordic Partners with UNICEF for Vaccine Supply
- Projected Surge in Contact Lenses Market to USD 16 Billion
- Fluidized Bed Concentrator Market Expected to Hit $4.9 Billion
- Power REIT's Path to Compliance: Equity Classification Success
- Discover Command Alkon's Innovative Cloud Solutions Ahead
- WiSA Unveils VerifyU: A Revolutionary Academic Verification Tool
- Savor Endless Tacos at On The Border: A Delightful Offer
- Pep Boys Welcomes New Interim CEO With Vast Experience
- Tether's Vision: Dirham-Pegged Stablecoin and More
- Burford Capital Celebrates 15 Years of Transforming Legal Finance
- Understanding the Price-to-Earnings Ratio of UPS Shares
- Randy Travis Receives Prestigious Music Fairness Award
- A $1000 Investment in Monolithic Power Systems: A Worthwhile Journey
- Harvest Canadian T-Bill ETF Announces Final Cash Distribution
- Unlock Your Access: FIFA World Cup 2026 Ticket Opportunity
- Transform Your Investment: The Growth Journey of KB Home
- Advancing Prostate Cancer Diagnostics in the Middle East
- Evaxion Biotech and Merck Forge New Partnership for Vaccines
- Claro Enterprise Solutions' Virtual Summit: A Cyber-Physical Future
- Pfizer's Withdrawal of Oxbryta: Implications for Sickle Cell Patients